# olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide

NDC: 49884-788
Generic name: olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Labeler / Manufacturer: Par Health USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20161026

FDA application: ANDA206137

## Active ingredients

- AMLODIPINE BESYLATE: 5 mg/1
- HYDROCHLOROTHIAZIDE: 25 mg/1
- OLMESARTAN MEDOXOMIL: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49884-788"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49884-788
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=268d12e8-1cfc-4086-b613-8fd94f2d7c4e